Ningbo Menovo Pharmaceutical Co.Ltd(603538) issued the announcement of stock trading changes. Recently, some investors have paid attention to “whether the company has arranged assisted reproduction, and elderly care business industries”. After verification by the company, the company’s main business does not involve assisted reproduction and elderly care industries. The company’s 32% equity participation of Ruihe fund invested 7.5% equity of Jiangsu Meike Medical Technology Co., Ltd. (hereinafter referred to as “Meike medical”). Ruihe fund and Meike medical are not within the scope of the company’s consolidated statements, and the proportion of equity participation is small. Merck medical’s business scope involves gynecological testing and assisted reproduction, but the two businesses account for a low proportion and have little impact on the company’s performance.
© China Stock Market News